Cargando…

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial

BACKGROUND: Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities of tenofovir disoproxil fumarate (TDF). SETTING: HIV-1–infected treatment-naive adults in India, South Africa,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venter, Willem Daniel Francois, Kambugu, Andrew, Chersich, Matthew F., Becker, Stephen, Hill, Andrew, Arulappan, Natasha, Moorhouse, Michelle, Majam, Mohammed, Akpomiemie, Godspower, Sokhela, Simiso, Poongulali, Selvamuthu, Feldman, Charles, Duncombe, Chris, Ripin, David H. Brown, Vos, Alinda, Kumarasamy, Nagalingeswaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2019
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358196/ https://www.ncbi.nlm.nih.gov/pubmed/30640204 http://dx.doi.org/10.1097/QAI.0000000000001908

Ejemplares similares

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial
por: Venter, Willem D. F., et al.
Publicado: (2017)

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir
por: Vos, Alinda G., et al.
Publicado: (2018)

Impact of COVID-19 on people living with HIV: A review
por: Prabhu, Sandeep, et al.
Publicado: (2020)

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
por: Sokhela, Simiso, et al.
Publicado: (2022)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients
por: Subashini, Dhakshinamoorthy, et al.
Publicado: (2018)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa
por: Chandiwana, Nomathemba C., et al.
Publicado: (2021)

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2016)

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
por: Balagopal, Ashwin, et al.
Publicado: (2016)

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India
por: Kausalya, Bagavathi, et al.
Publicado: (2022)

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials
por: Tovar Sanchez, Tamara, et al.
Publicado: (2023)

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells
por: Pallikkuth, Suresh, et al.
Publicado: (2018)

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
por: Sudharshan, Sridharan, et al.
Publicado: (2020)

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
por: Pepperrell, Toby, et al.
Publicado: (2020)

Long-term safety and immunogenicity of the M72/AS01(E) candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018)

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa
por: Sokhela, Simiso, et al.
Publicado: (2022)

Post-dispensing stability surveillance: Stavudine
por: Naidoo, Kamsaladevi K., et al.
Publicado: (2009)

Formulation and evaluation of floating matrix tablet of stavudine
por: Prajapati, Pankaj H, et al.
Publicado: (2012)

Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection
por: Jeyaraman, Vijay Ananth, et al.
Publicado: (2013)

Formulation and Evaluation of Controlled Release Floating Microballoons of Stavudine
por: Vidyadhara, Suryadevara, et al.
Publicado: (2015)

A Case of Lactic Acidosis Caused by Stavudine in an AIDS Patient
por: Cho, Byoung Chul, et al.
Publicado: (2004)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Triple trouble: A case of retinochoroiditis in a patient with syphilis, tuberculosis, and human immunodeficiency virus infection
por: Latif, Neethu, et al.
Publicado: (2020)

Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi
por: van Oosterhout, Joep J., et al.
Publicado: (2012)

Stavudine induced acute necrotizing pancreatitis with tetany in a pediatric patient
por: Patel, Mahendra K., et al.
Publicado: (2012)

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
por: Mokgethi, Nomcebo Oratile, et al.
Publicado: (2022)

beta-estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL
por: Zhang, Mingjie, et al.
Publicado: (2008)

Noninferiority trials
por: Snapinn, Steven M
Publicado: (2000)

Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial
por: Chen, Jun, et al.
Publicado: (2020)

Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
por: Steegen, Kim, et al.
Publicado: (2023)

Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology
por: Dey, Sanjay, et al.
Publicado: (2011)

Oral Disintegration Tablets of Stavudine for HIV Management: A New Technological Approach
por: Sankar, V., et al.
Publicado: (2012)

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
por: Siedner, Mark J., et al.
Publicado: (2020)

Simultaneous presentation of ocular surface squamous neoplasia with viral retinitis in HIV-positive patients with low CD4 counts
por: Rajagopal, Rama, et al.
Publicado: (2019)

Understanding noninferiority trials
por: Hahn, Seokyung
Publicado: (2012)

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
por: Gray, Lachlan R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_onhc0p4f2ql49i5464hfj25pmm